Ligands targeting PSMA for locating ovarian cancer seem to be a feasible approach, as [68Ga]Ga‐PSMA‐11 showed increased tumour uptake on PET/CT, corresponding with contrast enhancement on diagnostic CT [44]. This evidence concerns the gene FOLH1 and neoplasm.